Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
ADMINISTRATION: Intramuscular, intravenous or subcutaneous
The problem of patients being told that they will not be receiving their injections due to the risk of spreading the Covid-19 virus has been the sole topic in telephone calls and emails to the society in the past two weeks
Anti-Inflammatory Properties:BPC-157 may exert anti-inflammatory effects, which are crucial in the healing process
From 1st week: Reduced pain (noticeable within 3-7 days) Decreased inflammation Improved range of motion Better sleep (reduced pain at night) By week 2-3: Significant pain reduction Return to light activity possible Improved tissue mobility Reduced morning stiffness Week 4-6: Major healing progress Return to normal activities for minor injuries Continued improvement for moderate injuries Tissue strength improving Week 6-8: Near complete recovery for minor injuries Significant improvement for moderate injuries Reduced risk of re-injury Can increase activity level safely Realistic expectations: BPC-157 might cut healing time by 30-50%
, .
In such cases, injections offer a more reliable and effective solution
